Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-24 @ 6:59 PM
NCT ID:
NCT05414357
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 39 to 69 years
* Patient with operated localized breast cancer who may or may not be starting adjuvant chemotherapy
* Patient with education level 3 "end of primary education"
* Patient with a good command of the French language
* Patient with access to the Internet from a computer at home
* Patient having signed the consent to participate in the study
* Patient with no pre-existing cognitive impairment at the time of cancer diagnosis
* Patient with a sleep complaint (ISI \> 7)
Exclusion Criteria:
* Patient with metastatic cancer
* Patient with a primary cancer other than breast cancer
* Patient with a history of neurological damage
* Patient with treated sleep apnea
* Patient with drug use or alcohol abuse (≥3 drinks/day on average and/or \>10 drinks/week)
* Patient with a treatment that has not been stabilized for at least 3 months (hypnotics, antidepressants, anxiolytics)
* Patient with a personality disorder and/or an evolving psychiatric pathology
* Patient with a contraindication to MRI (claustrophobia, metallic objects in the body)
* Patient with an uncorrected vision problem
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
45 Years
Maximum Age:
65 Years
Study:
NCT05414357
Study Brief:
Protocol Section:
NCT05414357